NeuroPace, Inc.
NeuroPace, Inc. (NPCE) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · NPCE · as of Jun 9, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
1
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
NeuroPace, Inc. insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 9, 2026
NPCE insider buying and selling by quarter
NPCE insider selling · NPCE insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 9, 2026
Active insiders
Most active in past 12 months · NPCE ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
NPCE executive sell shares · NPCE board member insider trading · NPCE insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Jun 5, 2026 | Huennekens R Scott Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Fischer Frank M Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Geiger Uri Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Kumar Rakhi Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Ryan Renee Director | Award | 2,890 | — | Form 4 |
| Jun 5, 2026 | Andrade Lisa Director | Award | 2,890 | — | Form 4 |
| Jun 3, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 1,255 | $20K | Form 4 |
| May 27, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 1,126 | $19K | Form 4 |
| May 27, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 358 | $6K | Form 4 |
| May 15, 2026 | Williams Patrick F. CFO | Award | 16,820 | — | Form 4 |
| May 15, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Award | 5,460 | — | Form 4 |
| May 15, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Award | 45,880 | — | Form 4 |
| Mar 24, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 1,341 | $18K | Form 4 |
| Mar 20, 2026 | Geiger Uri Director | Award | 913 | $12K | Form 4 |
| Mar 20, 2026 | LACOB JOSEPH Director | Award | 865 | $11K | Form 4 |
| Mar 20, 2026 | Kumar Rakhi Director | Award | 1,153 | $15K | Form 4 |
| Mar 20, 2026 | Fischer Frank M Director | Award | 1,826 | $24K | Form 4 |
| Dec 15, 2025 | Morrell Martha CHIEF MEDICAL OFFICER | Sale | 25,000 | $399K | Form 4 |
| Mar 3, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 1,340 | $19K | Form 4 |
| Mar 3, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 5,023 | $69K | Form 4 |
| Feb 27, 2026 | Becker Joel CHIEF EXECUTIVE OFFICER · Director | Other | 1,126 | $16K | Form 4 |
| Feb 27, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 358 | $5K | Form 4 |
| Feb 20, 2026 | Morrell Martha CHIEF MEDICAL OFFICER | Other | 3,412 | $49K | Form 4 |
| Dec 19, 2025 | LACOB JOSEPH Director | Award | 678 | $11K | Form 4 |
| Dec 19, 2025 | Kumar Rakhi Director | Award | 904 | $15K | Form 4 |
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
Date
Jun 3
Shares
1,255
Price
$15.88
Value
$20K
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
Date
May 27
Shares
1,126
Price
$17.06
Value
$19K
Morrell Martha
CHIEF MEDICAL OFFICER
Date
May 27
Shares
358
Price
$17.06
Value
$6K
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
Date
May 15
Shares
45,880
Price
—
Value
—
Morrell Martha
CHIEF MEDICAL OFFICER
Date
Mar 24
Shares
1,341
Price
$13.27
Value
$18K
Morrell Martha
CHIEF MEDICAL OFFICER
Date
Dec 15
Shares
25,000
Price
$15.97
Value
$399K
Morrell Martha
CHIEF MEDICAL OFFICER
Date
Mar 3
Shares
1,340
Price
$13.83
Value
$19K
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
Date
Mar 3
Shares
5,023
Price
$13.83
Value
$69K
Becker Joel
CHIEF EXECUTIVE OFFICER · Director
Date
Feb 27
Shares
1,126
Price
$14.58
Value
$16K
Morrell Martha
CHIEF MEDICAL OFFICER
Date
Feb 27
Shares
358
Price
$14.58
Value
$5K
Morrell Martha
CHIEF MEDICAL OFFICER
Date
Feb 20
Shares
3,412
Price
$14.34
Value
$49K
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About NPCE insider trading
NPCE insider trades
NeuroPace, Inc. (NPCE) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including Morrell Martha (CHIEF MEDICAL OFFICER), Becker Joel (CHIEF EXECUTIVE OFFICER · Director), Fischer Frank M (Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. NPCE insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For NeuroPace, Inc.'s institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
NPCE insider trading · 5 questionsThe insiders of NeuroPace, Inc. (NPCE) include executives and directors such as Morrell Martha (CHIEF MEDICAL OFFICER), Becker Joel (CHIEF EXECUTIVE OFFICER · Director), Fischer Frank M (Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 9, 2026